PREvention of CardIovascular and DiabEtic KidNey Disease in Type 2 Diabetes

Study Purpose: We are doing PRECIDENTD to learn more about diabetes medications that also reduce the risk of heart and kidney disease in people with type 2 diabetes.
Study Duration: 8 years
Study Commitment: 1 screening visit/baseline (remote or in-person) (2-3hr);
Follow up visits at two months, 12 months, and then every year thereafter for year 2,3,4,5,6,7, and 8 (remote or in-person); Telephone visit 6 months after every annual visit (30-min)
Age: 40-80 years old
Sex: Male & Female
Conditions/Eligibility: Male and females, 40 - 80 years old, who have type 2 diabetes and have a history of heart or blood vessel disease or are at high risk for heart disease based on your other health conditions such as active smoking, HbA1c ≥ 8%, or kidney disease.
Study Procedures: Study visits; study questionnaires (medical history, medication history, and current health); routine blood collection; diabetes medication management
Compensation: Up to $3000